Alveolar Bone Loss, Bone Density Increased
Conditions
Brief summary
The present study is a human, prospective, randomised controlled clinical trial conducted to explore the outcome of a minimally invasive ridge augmentation technique with and without low level laser therapy. The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.
Detailed description
Twenty healthy individuals satisfying the inclusion and exclusion criteria were recruited for the study. A detailed, thorough medical and dental history was obtained and each patient was subjected to comprehensive clinical and radiological examination. All patients were informed about the nature of the study, the surgical procedure involved, potential benefits and risks associated with the surgical procedure and written informed consent were obtained from all patients. All the patients were treated with subperiosteal minimally invasive aesthetic ridge augmentation technique. the test group of ten were given low level laser therapy as an adjunct. The clinical and radiographic parameters were recorded at baseline and six months postoperatively.
Interventions
DEVICELow Level Laser Therapy
Hydroxyapatite bone graft with collagen
Sponsors
Krishnadevaraya College of Dental Sciences & Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Intervention model description
Two groups were made one test and control. The control group were treated with MINIMALLY INVASIVE RIDGE AUGMENTATION technique alone and the test group were treated with adjunctive low-level laser therapy for bone regeneration.
Eligibility
Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Single or multiple edentulous sites with Seibert's class 1 defects corresponding to colognes 1 and 2 * ASA 1 and 2 * Patients with an esthetic concern * Good oral hygiene
Exclusion criteria
* Seibert's class 2 defects * ASA 3 and 4 * Osteoporosis * uncontrolled diabetes * immunosuppression * radiation therapy and bisphosphonate therapy * Gingival thickness less than 2 mm
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Gain in Alveolar ridge width in millimeters | 6 months | gain in alveolar ridge width at the agumented site in millimeters will be measured using Cone Beam Computed Tomography (CBCT) at baseline and six months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Bone density in Hounsefield's units | 6 months | Change in Bone density in Hounsefield units will be measured using Cone Beam Computed Tomography (CBCT) at baseline and six months |
| Patient related outcomes of the surgical procedure in relation to 1) pain 2) discomfort and 3) swelling | one week | Patient related outcomes during and after the procedure will be recorded |
Countries
India
Outcome results
None listed